Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-02-17
Product name
HYCAMTIN INJECTABLE
Product Synonyms
HYCAMTIN INFUSION 1 MG/3 ML * HYCAMTIN INJECTION 1 MG/3 ML * HYCAMTIN INJECTION
supplier name
GlaxoSmithKline Korea
Emergency telephone
+82 2 709 4114, +(82) 02 64339507, +080 822 1365, +(1) 760 476 3960
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
category/Classification Physical hazards Health hazards Environmental hazards Not classified. Acute toxicity, oral Category 2 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 1 Carcinogenicity Category 1B Reproductive toxicity Category 1B Specific target organ toxicity following single Category 1 exposure B. Warning label items including precautionary statement • Pictogram • Signal word Danger • Hazard statement H300 Fatal if swallowed. H318 Causes serious eye damage. H340 May cause genetic defects. H350 May cause cancer. H360 May damage fertility or the unborn child. H370 Causes damage to organs.
Precautionary statements
Prevention P201 P202 P260 P264 P270 P280 Response P301 + P310 P330 P305 + P351 + P338 P310 Storage P405 Disposal P501 Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves/protective clothing/eye protection/face protection. IF SWALLOWED: Immediately call a POISON CENTRE or doctor/physician. Rinse mouth. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE or doctor/physician. Store locked up. Dispose of contents/container to
Other hazards
not included in the hazard category criteria (e.g. dust explosion hazard) Supplemental information Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. 10 % of the mixture consists of component(s) of unknown acute dermal toxicity.
2.1 Classification of the substance or mixture
Physical hazards Not classified. Health hazards Acute toxicity, oral Category 2 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 1 Carcinogenicity Category 1B Reproductive toxicity Category 1B Specific target organ toxicity following single Category 1 exposure Environmental hazards Not classified.
